Published July 5, 2018
| Version v2
Dataset
Open
Screening compounds of interest against USP5 Zf-UBD with a surface plasmon resonance assay
- 1. University of Toronto, Structural Genomics Consortium
Description
The determination of binding affinities of compounds of interest against USP5 zinc finger ubiquitin binding domain (Zf-UBD) with a surface plasmon resonance (SPR) assay.
Notes
Funding Acknowledgment: The SGC is a registered charity (number 1097737) that receives funds from AbbVie, Bayer Pharma AG, Boehringer Ingelheim, Canada Foundation for Innovation, Eshelman Institute for Innovation, Genome Canada through Ontario Genomics Institute [OGI-055], Innovative Medicines Initiative (EU/EFPIA) [ULTRA-DD grant no. 115766], Janssen, Merck KGaA, Darmstadt, Germany, MSD, Novartis Pharma AG, Ontario Ministry of Research, Innovation and Science (MRIS), Pfizer, São Paulo Research Foundation-FAPESP, Takeda, and Wellcome.
Files
20180705 SPR.pdf
Files
(1.2 MB)
| Name | Size | Download all |
|---|---|---|
|
md5:72714c38f3b84fa583950136018c5455
|
459.9 kB | Preview Download |
|
md5:de8928cd8bc62de00b55f950ddac13f1
|
759.9 kB | Preview Download |